Antiarrhythmic agents: Current status and perspectives

Medicinal Research Reviews

Volumn 17, Issue 5, 1997, Pages 427-451

  Mátyus, Péter ^{a,c,d,e,f,g,h,i}   Varró, András ^a,b,j,k   Papp, Julius Gy ^b,i,l,m   Wamhoff, Heinrich ^c,n   Varga, Ildikó ^a,e,h,o   Virág, László ^b,e,p,q  

^a Institute for Drug Research Budapest   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF BONN   (Germany)

^d SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^e BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

^f KYOTO UNIVERSITY   (Japan)

^g AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^h Institute for Drug Research

ⁱ INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^j UNIVERSITY OF CINCINNATI   (United States)

^k UNIVERSITY OF LIVERPOOL   (United Kingdom)

^l UNIVERSITY OF PÉCS   (Hungary)

^m UNIVERSITY OF OXFORD   (United Kingdom)

ⁿ Chemical Faculty

^o Chinoin Pharmaceutical and Chemical Works Ltd   (Hungary)

^p UNIVERSITY OF SZEGED   (Hungary)

^q TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

more..

Author keywords

Antiarrhythmic agents; Arrhythmias; Ion channels; Molecular modeling; Structure activity relationships

Indexed keywords

1,1 DIMETHYL 3 (2,6 XYLIDINO)GUANIDINE; AMIODARONE; ANTIARRHYTHMIC AGENT; APRINDINE; AZIMILIDE; BIDISOMIDE; BISARAMIL; CARIPORIDE; DETAJMIUM BITARTRATE; DISOPYRAMIDE; ENCAINIDE; FLECAINIDE; INDECAINIDE; ION CHANNEL; LIDOCAINE; LORCAINIDE; MEXILETINE; MORACIZINE; N (2 DIMETHYLAMINOPROPYL) 2,6 DIMETHYLANILINE; N (3,4 DIMETHOXYPHENYL) N [3 [N [2 (3,4 DIMETHOXYPHENYL)ETHYL] N METHYLAMINO]PROPYL] 4 NITROBENZAMIDE; PIRMENOL; POTASSIUM CHANNEL BLOCKING AGENT; PRAJMALINE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; RO 22 9194; SODIUM CHANNEL BLOCKING AGENT; TOCAINIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

HEART ARRHYTHMIA; HUMAN; MOLECULAR MODEL; POTASSIUM CURRENT; REVIEW; SODIUM CURRENT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; HEART CONDUCTION SYSTEM; HUMANS; ION CHANNELS; MODELS, MOLECULAR; POTASSIUM CHANNELS; SODIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0342940547     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1128(199709)17:5<427::AID-MED1>3.0.CO;2-W     Document Type: Review

References (164)

1. J. E. Dalen, Arch. Intern. Med., 151, 1922 (1991).
2. Z. H. Zhang, C. H. Follmer, J. S. M. Sarma, F. Chen, and B. N. Singh, J. Pharmacol. Exp. Ther., 263, 40 (1992).
3. The CAST Investigators, N. Engl. J. Med., 321, 406 (1989).
4. The CAST II Investigators, N. Engl. J. Med., 327, 227 (1992).
5. R. E. Sperry, K. A. Ellenbogen, M. A. Wood, M. K. Belz, and B. S. Stambler, PACE, 16, 2202 (1993).
6. E. N. Prystowsky, W. Benson, V. Fuster, R. G. Hart, G. N. Ray, R. J. Myerburg, G. V. Naccarelli, and D. G. Wyse, Circulation, 93, 1262 (1996).
7. E. M. Vaughan Williams, Pharmacol. Therap., B1, 115 (1975).
8. B. Surawicz, in Electrophysiologic Basis of ECG and Cardiac Arrhythmias, Williams and Wilkins, Baltimore-Philadelphia-Honkong-London-Munich-Sydney-Tokyo, 1995, p. 471.
9. T. J. Colatsky and T. M. Argentieri, Drug Devel. Res., 33, 235 (1994).
10. S. A. Rees and M. J. Curtis, Pharmacol. Ther., 69, 199 (1996).
11. S. Mattel, Am. Heart J., 130, 1094 (1995).
12. M. R. Rosen, Eur. Heart J., 16 (Suppl. G), 32 (1995).
13. K. Hallman and L. Carlsson, Pharm. Toxicol., 77, 250 (1995).
14. C. F. Starmer, D. N. Romashko, R. S. Reddy, Y. I. Zilberter, J. Starobin, A. O. Grant, and V. I. Krinsky, Circulation, 92, 595 (1995).
15. The SWORD Investigators, SCRIP No 1973, 23 (1994).
16. The DIAMOND Investigators, SCRIP No 1985, 25 (1995).
17. L. Ceremuzynski, Am. J. Cardiol., 72, 82F (1993).
18. J. J. Garguichevich, J. L. Ramos, A. Gamberte, A. Gentile, S. Haud, O. Scapin, J. Sirena, M. Tibaldi, and J. Toplikar, Am. Heart J., 130, 494 (1995).
19. S. N. Singh, M. D. Ross, R. D. Fletcher, S. G. Fisher, B. N. Singh, H. D. Lewis, P. C. Deedwania, B. M. Massie, C. Colling, and D. Lazzeri, N. Eng. J. Med., 333, 77 (1995).
20. B. F. Hoffman and M. R. Rosen, Circ. Res., 49, 1 (1981).
21. G. A. Gintant and I. S. Cohen, Ann. Rev. Pharmacol. Toxicol., 28, 61 (1988).
22. D. M. Roden, Eur. Heart J., 14 (Suppl. H), 56 (1993).
23. D. M. Roden and A. L. George, Ann. Rev. Med., 47, 135 (1996).
24. A. O. Grant, Jr. and N. C. Durham, Am. Heart J., 123, 1130 (1992).
25. T. J. Campbell, Antiarrhytmic Drugs, E. M. Vaughan Williams, Ed., Springer, Berlin, 1989, p. 135.
26. L. M. Hondeghem and B. G. Katzung, Ann. Rev. Pharmacol. Toxicol., 24, 387 (1984).
27. A. Varró, V. Elharrar, and B. Surawicz, J. Cardiovasc. Pharmacol., 7, 482 (1985).
28. H. Langenfeld, J. Weirich, C. Köhler, and K. Kochsiek, J. Cardiovasc. Pharmacol., 115, 338 (1990).
29. J. H. Lee and M. R. Rosen, J. Cardiovasc. Pharmacol., 18, 285 (1991).
30. M. I. Steinberg and S. A. Wiest, J. Cardiovasc. Pharmacol., 6, 614 (1984).
31. O. Hála, M. Németh, A. Varró, and J. Gy. Papp, J. Cardiovasc. Pharmacol., 24, 559 (1994).
32. A. Varró, T. K. Knilans, P. P. Nánási, Gy. Rabloczky, and D. A. Lathrop, Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 691 (1990).
33. J. P. Arena, J. J. McArdle, and S. Laxminarayan, J. Pharmacol. Exp. Ther., 240, 441 (1987).
34. T. J. Campbell, J. Cardiovasc. Pharmacol., 5, 291 (1983).
35. T. J. Campbell and E. M. Vaughan Williams, Cardiovasc. Res., 17, 251 (1983).
36. E. Winslow, M. Martorana, and P. Bell, J. Cardiovasc. Pharmacol., 14, 205 (1989).
37. R. Rouet, C. C. Libersa, F. Broly, J. F. Caron, M. M. Adamantidis, E. Monore, A. Wajman, and B. A. Dupuis, J. Cardiovasc. Pharmacol., 14, 577 (1989).
38. T. Shirayama, D. Inoue, M. Inoue, T. Tatsumi, Y. Yamahara, J. Asayama, H. Katsume, and M. Nakagawa, J. Pharmacol. Exp. Ther., 259, 884 (1991).
39. A. Varró, M. Németh, Gy. Rabloczky, J. Gy. Papp, and L. Szekeres, J. Cardiovasc. Pharmacol., 11, 251 (1988).
40. M. Kojima, M. Ichiyama, and T. Ban, J. Mol. Cell. Cardiol., 18, 711 (1986).
41. A. Varró, Y. Nakaya, and V. Elharrar, Eur. J. Pharmacol., 112, 419 (1985).
42. A. Varró, H. Saitoh, and B. Surawicz, J. Cardiovasc. Pharmacol., 10, 407 (1987).
43. S. Oshita, H. Sada, M. Kojima, and T. Ban, Naunyn-Schmiedeberg's Arch. Pharmacol., 314, 67 (1980).
44. K. R. Courtney, J. Mol. Cell. Cardiol., 12, 1273 (1980).
45. IMPACT Research Group, Eur. Heart J., 7, 740 (1986).
46. M. T. Slawsky and N. A. Castle, J. Pharmacol. Exp. Ther., 269, 66 (1994).
47. Y. Imaizumi and W. R. Giles, Am. J. Physiol., 253, H704 (1987).
48. D. Duan, B. Fermini, and S. Nattel, J. Pharmacol. Exp. Ther., 264, 1113 (1993).
49. E. Delpon, C. Valenzuela, O. Perez, O. Casis, and J. Tamargo, Circ. Res., 76, 223 (1995).
50. E. Wettwer, M. Grundke, and U. Ravens, Cardiovasc. Res., 26, 1145 (1992).
51. M. Hiraoka, K. Sawada, and S. Kawano, J. Mol. Cell. Cardiol., 18, 1097 (1986).
52. E. Carmeliet, Cardiovasc. Drugs Ther., 7, 599 (1993).
53. D. W. Wang, T. Kiyosue, T. Sato, and M. Arita, J. Mol. Cell. Cardiol., 28, 893 (1996).
54. Z. Wang, B. Fermini, and S. Nattel, J. Pharmacol. Exp. Ther., 267, 575 (1993).
55. A. Varró, L. Virág, and J. Gy. Papp, Br. J. Pharmacol., 117, 1181 (1996).
56. E. Carmeliet, J. Pharmacol. Exp. Ther., 262, 809 (1992).
57. E. Carmeliet, Circ. Res., 73, 857 (1993).
58. H. Nakaya, N. Toshe, Y. Takada, and M. Kanno, Br. J. Pharmacol., 109, 157 (1993).
59. T. Sawanobori, H. Adaniya, T. Namiki, and M. Hiraoka, J. Pharmacol. Exp. Ther., 271, 302 (1994).
60. B. Fermini, N. K. Jurkiewicz, B. Jow, P. J. Guinosso, E. P. Baskin, J. J. Lynch, and J. J. Salata, J. Cardiovasc. Pharmacol., 26, 259 (1995).
61. Z. H. Zhang, C. H. Follmer, J. S. M. Sarma, F. Chen, and B. N. Singh, J. Pharmacol. Exp. Ther., 263, 40 (1992).
62. N. K. Jurkiewicz and M. C. Sanguinetti, Circ. Res., 72, 75 (1993).
63. A. E. Busch, K. Malloy, W. J. Groh, M. D. Varnum, J. P. Adelman, and J. Maylie, Biochem. Biophys. Res. Com., 202, 265 (1994).
64. L. M. Hondeghem and D. J. Snyders, Circulation, 81, 686 (1990).
65. J. Weirich, Basic. Res. Cardiol., 87, 205 (1992).
66. M. C. Sanguinetti and N. K. Jurkiewicz, J. Gen. Physiol., 96, 195 (1990).
67. A. Bahinsky, D. Anderson, M. S. Carlos Oliva, and D. Tatla, PACE, 19, 664 (1996).
68. G. A. Gintant, Circ. Res., 78, 26 (1996).
69. S. Ito and B. Surawicz, Am. J. Physiol., 241, H139 (1981).
70. A. E. Tararak, I. N. Merkulova, and M. Y. Ruda, J. Mol. Cell. Cardiol., 27, A193 (1995).
71. H. Poppe and R. Bartsch, 1st European Congress of Pharmacology, Milan, Italy, 16-19 June 1995.
72. D. Marx, H. Poppe, and R. Bartsch, Arch. Pharmacol., 351 (Suppl.), R106 (1995).
73. H. Poppe and R. Bartsch, Arch. Pharmacol., 351 (Suppl.), R107 (1995).
74. N. V. Kaverina, V. V. Lyskovstev, and S. F. Sokolov, J. Mol. Cell. Cardiol., 27, A192 (1995).
75. German Pat. DE 4 344 648.
76. J. M. Elliott, H. G. Selnick, D. A. Claremon, J. J. Baldwin, S. A. Buhrow, J. W. Butcher, C. N. Habecker, S. W. King, J. J. Lynch, B. T. Phillips, G. S. Ponticello, E. M. Radzilowski, D. C. Remy, R. B. Stein, J. I. White, and M. B. Young, J. Med. Chem., 35, 3973 (1992).
77. U.S. Pat. 5 403 846.
78. U.S. Pat. 5 439 914.
79. Int. Pat. WO 9 607 411.
80. Pharmaprojects, 17 (Therap. Categ. Main Vol.), p. 276a (1996).
81. Eur. Pat. EP 665 014.
82. G. A. Gintant, 67th Scientific Session of the American Heart Association, Dallas, TX, USA, 14-17 November 1994, Poster 0781.
83. M. Lamorgese, M. Kirian, and D. R. Van Wagoner, 68th Scientific Session of the American Heart Association, Anaheim, CA, USA, 13-16 November 1995, Poster 2749.
84. A. E. Busch, K. J. Malloy, M. D. Varnum, J. P. Adelman, R. A. North, and J. Maylie, Biochem. Biophys. Res. Commun., 202, 265 (1994).
85. T. Yang, D. J. Snyders, and D. M. Roden, Circulation, 91, 1799 (1995).
86. Int. Pat. WO 9 608 471.
87. J. W. Ellingboe, W. Spinelli, M. W. Winkley, T. T. Nguyen, R. W. Parsons, I. F. Moubarak, J. M. Kitzen, D. Von Engen, and J. F. Bagli, J. Med. Chem., 35, 705 (1992).
88. Int. Pat. WO 9 514 470.
89. J. Y. Lee, K. Lee, H. S. Shin, H. Y. Kim, and S. Tanabe, Experimental Biology '96, Washington, D.C., USA, 14-11 April 1996, Poster 179.
90. K. Lee, L. S. Kwon, H. Y. Kim, and S. Tanabe, Experimental Biology '96, Washington, D.C., USA, 14-17 April 1996, Poster 180.
91. A. Varró and J. Gy. Papp, Cardioscience, 3, 131 (1992).
92. T. Opthof, Cardiovasc. Res., 28, 420 (1994).
93. S. A. Rees and M. J. Curtis, Circulation, 87, 1979 (1993).
94. Eur. Pat. EP 697 407.
95. J. Kiehn, P. Villena, T. Beyer, and J. Brachman, J. Cardiovasc. Pharmacol., 24, 566 (1994).
96. A. Varró, P. P. Nánási, and D. A. Lathrop, Life Sci., 49, PL-7 (1991).
97. C. Antzelevitch, S. Sicouri, S. H. Litovsky, A. Lukas, S. C. Krishnan, J. M. Di Diego, G. A. Gintant, and D. W. Liu, Circ. Res., 69, 1427 (1991).
98. I. D. Dukes, L. Cleemann, and M. Morad, J. Pharmacol. Exp. Ther., 254, 560 (1990).
99. I. Findlay, J. Cardiovasc. Pharmacol., 24 (Suppl. 4), S6 (1994).
100. M. Kakei, A. Noma, and T. Shibasaki, J. Physiol., 363, 441 (1985).
101. A. Tosaki, P. Szerdahelyi, R. M. Engelman, and D. K. Das, J. Pharmacol. Exp. Ther., 267, 1355 (1993).
102. G. S. Friedrichs, L. Chi, S. C. Black, P. J. Manlry, J. Y. Oh, and B. R. Lucchesi, J. Pharmacol. Exp. Ther., 266, 1348 (1993).
103. D. K. Martin, Y. Nakaya, K. R. Wyse, J. A. Bursill, P. D. West, and T. J. Campbell, Pharmacol. Toxicol., 77, 65 (1995).
104. B. Wu, T. Sato, T. Kiyosue, and M. Arita, Cardiovasc. Res., 26, 1095 (1992).
105. F. Cacciapuoti, R. Spiezia, U. Bianchi, D. Lama, M. D'Avino, and M. Varricchio, Am. J. Cardiol., 67, 843 (1991).
106. W. C. Cole, C. D. McPherson, and D. Sontag, Circ. Res., 69, 571 (1991).
107. G. J. Gross and J. A. Auchampach, Circ. Res., 70, 223 (1992).
108. M. J. Kerr, R. Wilson, and R. G. Shanks, J. Cardiovasc. Pharmacol., 7, 875 (1985).
109. I. Leprán, I. Baczkó, A. Varró, and J. Gy. Papp, J. Pharmacol. Exp. Ther., in press.
110. G. J. Gross, Basic Res. Cardiol., 90, 85 (1995).
111. Eur. Pat. EP 661 264.
112. A. Varró and J. Gy. Papp, J. Cardiovasc. Pharmacol., 26 (Suppl. 1), S32 (1995).
113. D. Buddish, G. Isenberg, U. Ravens, and G. Scholtysik, Eur. J. Pharmacol., 118, 303 (1985).
114. T. Ozaki, T. Uematsu, S. Nagashima, M. Nishimoto, and M. Nakashima, Naunyn-Schmiedeberg's Arch. Pharmacol., 344, 478 (1991).
115. K. G. Estep, K. A. Josef, E. R. Bacon, P. M. Carabateas, S. Rumney IV, G. M. Pilling, D. S. Krafte, A. Volberg, K. Dillon, N. Dugrenier, G. M. Briggs, P. C. Canniff, W. P. Gorczyca, G. P. Stankus, and A. M. Ezrin, J. Med. Chem., 38, 2582 (1995).
116. J. W. Mason, L. M. Hondeghem, and B. G. Katzung, Circ. Res., 55, 277 (1984).
117. S. Sicouri, S. Moro, L. N. Siri, M. V. Elizari, S. Litovski, and C. Antzelevitch, PACE, 19, 538 (1996).
118. A. Varró, J. Gy. Papp, M. Németh, I. Krassói, L. Mester, and O. Hála, Br. J. Pharmacol., 117, 226P (1996).
119. R. Lazzara, Ann. Intern. Med., 111, 549 (1989).
120. G. Breithardt, N. Eng. J. Med., 333, 121 (1995).
121. P. B. Bennett and T. B. Begenisch, Pflügers Arch., 410, 217 (1987).
122. S. Yusuf, G. Venkatesh, and K. K. Teo, Am. J. Cardiol., 72, 72F (1993).
123. M. J. Raatikainen, J. R. Martens, P. Druzgala, and D. M. Dennis, 68th Scientific Session of the American Heart Association, Anaheim, CA, USA, 13-16 November 1995, Poster 2755.
124. E. Novalija, A. H. Kulier, J. Woehlck, J. L. Atlee, and Z. J. Bosnjak, Experimental Biology '95, Atlanta, GA, USA, 9-13 April 1995, Poster 3493.
125. R. E. Johnson, E. R. Baizman, C. Becker, E. A. Bohnet, R. H. Bell, N. C. Birsner, C. A. Busacca, P. M. Carabateas, C. C. Chadwick, M. D. Gruett, J. T. Hane, J. L. Herrmann, K. A. Josef, D. S. Krafte, R. K. Kullnig, W. F. Michne P. A. Pareene, R. B. Perni, B. O'Connor, U. J. Salvador, M. A. Sanner, D. C. Schlegel, P. J. Silver, J. Swestock, G. P. Stankus, J. H. Tatlock, W. A. Volberg, C. C. Weigelt, and A. M. Erzin, J. Med. Chem., 36, 3361 (1993).
126. G. L. Garrison, K. D. Berlin, B. J. Scherlag, R. Lazzara, E. Patterson, T. Fazekas, S. Sangiah, C. L. Chen, F. D. Schubot, and D. van der Helm, J. Med. Chem., 39, 2559 (1996).
127. J. Weisenburger, F. Chézalviel-Guilbert, J. M. Davy, J. M. Poirier, and G. Cheymol, Can. J. Physiol. Pharmacol., 72 (Suppl. 1), P.1.1.37 (1994).
128. Int. Pat. WO 9 526 726.
129. J. F. Faivre, S. Rouanet, and A. Bril, Experimental Biology '96, Washington, D.C., USA, 14-17 April 1996, Poster 375.
130. A. Bril, C. Dusseau, M. C. Forest, B. Cheval, and J. F. Faivre, Experimental Biology '96, Washington, D.C., USA, 14-17 April 1996, Poster 374.
131. B. Gout, M. Bonhomme, and A. Bril, Experimental Biology '96, Washington, D.C., USA, 14-17 April 1996, Poster 376
132. A. Bril, M. Bonhomme, and B. Gout, Experimental Biology '95, Atlanta, GA, USA, 9-13 April 1995, Poster 3510.
133. A. Bril, M. Bonhomme, L. Landais, J. F. Faivre, and P. Linee, Eur. Heart J., (Abstr. Suppl.), 189 (1994).
134. B. Gout, J. Jean, and A. Bril, Experimental Biology '95, Atlanta, GA, USA, 9-13 April 1995, Lecture 3236.
135. Int. Pat. WO 9 507 903.
136. Int. Pat. WO 9 507 884.
137. French Pat. FR 2 707 985.
138. Brit Pat. GB 2 286 529.
139. M. Protiva, Drugs Fut., 18, 1143 (1993).
140. A. Kovács, I. Gyönös, J. Wellmann, P. Nánási, C. Pankucsi, and G. Szénâsi, J. Mol. Cell. Cardiol., 28, A59 (1996).
141. S. Dhein and T. Tudyka, Drugs, 49, 851 (1995).
142. S. Dhein, N. Manicone, A. Müller, R. Gerwin, U. Ziskoven, A. Irankhahi, A. Minke, and W. Klaus, Naunyn-Schmiedeberg's Arch. Pharmacol., 350, 174 (1994).
143. K. R. Latham, D. F. Sellitti, and R. E. Goldstein, J. Am. Coll. Cardiol., 9, 872 (1987).
144. J. Parratt, A. Végh, and J. Gy. Papp, Pharmacol. Res., 31, 225 (1995).
145. C. F. Stramer, A. O. Grant, and H. C. Strauss, Biophys. J., 46, 15 (1984).
146. I Kodama, H. Honjo, K. Kamiya, and J. Toyama, J. Mol. Cell. Cardiol., 22, 1 (1990).
147. K. Kamiya, J. Toyama, H. Honjo, and I. Kodama, Pharmacology, 44, 260 (1992).
148. D. A. Hanck, J. C. Makielski, and M. F. Sheets, J. Gen. Physiol., 103, 19 (1994).
149. R. S. Sheldon, N. J. Cannon, and H. J. Duff, Circ. Res., 61, 492 (1987).
150. R. S. Sheldon and E. Thakore, Am. Soc. Pharmacol. Exp. Ther., 272, 1005 (1995).
151. Z. Feng, Y. Liu, X. Zhu, and W. Wang, Med. Chem. Res., 2, 28 (1992).
152. K. Hasegawa, Y. Miyashita, and S. I. Sasaki, Chemom. Intell. Lab. Syst., 16, 69 (1992).
153. M. Remko, S. Scheiner, and B. M. Rode, J. Mol. Struct., (THEOCHEM) 307, 35 (1994).
154. S. Marrer, Pharm. Acta Helv., 64, 338 (1989).
155. M. L. Glówka, R. L. Dargie, and P. W. Codding, J. Med. Chem., 34, 2678 (1991).
156. N. S. Cook, Potassium Channels, Ellis Horwood Ltd., Chichester, 1990.
157. A. E. Busch, S. Waldegger, and F. Lang, Drug News & Perspectives, 8, 278 (1995).
158. A. M. Katz, N. Eng. J. Med., 328, 1244 (1993).
159. D. J. Snyders and S. W. Yeola, Circ. Res., 77, 575 (1995).
160. C. T. Alabaster, P. E. Cross, and H. W. Dalrymple, Drug News & Perspectives 6, 265 (1993).
161. M. Gwilt, J. J. Blackburn, R. A. Burges, A. J. Higgins, A. A. Milne, and A. M. Solca, Eur. J. Pharmacol., 215, 137 (1992).
162. R. E. Johnson, P. J. Silver, R. Becker, N. C. Birsner, E. A. Bohnet, G. M. Briggs, C. A. Busacca P. Canniff, P. M. Carabateas, C. C. Chadwick, T. D'Ambra, R. L. Dundore, J. Dung, A. M. Ezrin, W. Gorczyca, P. G. Habeeb, P. H. D. S. Krafte, C. M. Pilling, B. O'Connor, M. T. Saindane, D. C. Schlegel, G. P. Stankus, J. Swestock, and W. A. Volberg, J. Med. Chem., 38, 2551 (1995).
163. C. H. Follmer, Z. Zhang, and B N. Singh, in Electropharmacological Control of Cardiac Arrhythmias, B. N. Singh, H. J. J. Wellens, and M. Hiraoka, Eds., Futura Publishing Co., New York, 1994, p. 611.
164. R. G, Hanna, J. W. Lampe, W. C. Lumma, Jr., P. W. Erhardt, S. S. Wong, and M. E. Sullivan, J. Med. Chem., 32, 688 (1989).